News and Comments

Good News for Agenus and for Global Blood Therapeutics

  Friday, June 10, 2016

Agenus (AGEN) announced that a lead product candidate is selected under its license and research collaboration with Merck, which is known as MSD outside the United States and Canada.   More...

COULD AGENUS VACCINE FOR GLIOBLASTOMA BE ASSIGNED BREAKTHROUGH DESIGNATION?

  Tuesday, September 17, 2013

AGENUS (AGEN) has extraordinary news. A recent analysis from a Phase 2 trial in patients with newly diagnosed glioblastoma multiforme (GBM) treated with Prophage Series G-100 (HSPPC-96) in combination with the current standard of care (radiation and temozolomide) showed an almost 18 month median progression free survival (PFS), which represents a 160% increase versus current standard of care alone. The results confirm continuation of the positive trends from the Phase 2 HSPPC-96 newly diagnosed GBM trial first reported at the 81st American Association of Neurological Surgeons (AANS) Annual Scientific Meeting in May 2013. More...


Recent Postings


Archive


Tags

Dynavax (DVAX) Global Cell Therapeutics (GBT) Ziofpharm (ZIOP) Sangamo (SGMO) Zerenex Agenus (AGEN OSI (OSIP) KITE (KITE) Biocryst (BCRX) Illumina (ILMN) Sanofi (SNY) SERES THERAPEUTICS (MCRB) Intermune (ITMN) Galena (GALE) AGOS (ARGS) Bristol-Myers Squibb (BMY) PTC Therapeutics (PTCT) ACADIA (ACAD) Alder Biopharmaceuticals (ALDR) ABBVIE (ABBV) Pluristem (PSTI) Intercept (ICPT) Telaprevir Elan (ELN) Prosensa (RNA) Gilead (GILD) Endometrial Cancer Mirati Therapeutics (MRTX) JUNO (JUNO) NEKTAR (NKTR)) Human Genome Sciences (HGSI) Velcade (bortezomib) Tysabri Inovio (INO) Benlysta (belimumab) galapagos (GLPG) IDERA (IDRA) Human Longevity (HLI) Herceptin Idenix (IDIX) VANDA (VNDA) Micromet (MITI) Onyx (ONXX) Dendreon (DNDN) Genentech Editas (EDIT) SYNTA (SNTA) Sarepta (SRPT) Cytokinetics (CYTK) ARCA (ABIO) ImmunoGen (IMGN) Prolor Biotech (PBTH) KERYX (KERX) Intrexon (XON) Regeneron (REGN) Rapamune Vitae Pharmaceuticals (VTAE) C4 Therapeutics Amgen (AMGN) Ionis (IONS) ARGOS (ARGS) NANTKWEST (NK) Trastuzumab-DM1 Anadys (ANDS) ZALTRAP™ RenenxBio (RGNX) CompuGen (CGEN) Alnylam (ALNY) Jazz Pharmaceuticals (JAZZ) Merck (MRK) Multiple Myeloma Seattle Genetics (SGEN) ISIS (ISIS) Aimmune Therapeutics (AIMT) Ariad (ARIA) GUARDIAN HEALTH Theravance Bio Pharma (TBPH) Xoma (XOMA) Anacor (ANAC) Sanofi (SNA) Incyte (INCY) Roche (RHHBY) HALOZYME (HALO) NOVOCURE (NVCR) Valeant Pharmaceuticals International (VRX) TOKAI (TKAOI) Biogen Idec (BIIB) Revlimid (lenolidamide) Roche (ROCHE) Abbott Laboratories (ABT) Agenus (AGEN) Theravance (THRX) INNOVIVA (INVA) Vertex (VRTX) REGULUS (RGLS) AERIE PHARMACEUTICALS Ridaforolimus Exelixis (EXEL) Sequenom (SQNM) Array Pharmaceuticals (ARRY) GlaxoSmithKline (GSK) SUNESIS PHARMACEUTICALS (SNSS) Spike Therapeutics (ONCE) BIOMARIN (BMRN) Auspex (ASPX) Sanofi-Aventis (SAN) ADVENTRIX (ANX)